Trial intelligence / Profile preview

Birch-associated soy allergy immunotherapy trial

ISRCTN67316358Phase 3Completed

Sponsor
Leipzig University
Start
Oct 2009
Modality
Subcutaneous Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Sublingual Immunotherapy → Allergy Immunotherapy → Therapeutic Vaccines → Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
01

Overview

Phase 3 trial of Bet v 1 allergen extract, sponsored by Leipzig University. Started Oct 2009; status: completed.

02

Drugs

Bet v 1 allergen extract

Beyond the preview

Go deeper on ISRCTN67316358.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN67316358.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call